Literature DB >> 12594601

Drotrecogin alfa (activated) for the treatment of meningococcal purpura fulminans.

Esther B Bachli, Stephan R Vavricka, Roland B Walter, Monika I Leschinger, Marco Maggiorini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12594601     DOI： 10.1007/s00134-002-1605-y

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  3 in total

1.  Efficacy and safety of recombinant human activated protein C for severe sepsis.

Authors:  G R Bernard; J L Vincent; P F Laterre; S P LaRosa; J F Dhainaut; A Lopez-Rodriguez; J S Steingrub; G E Garber; J D Helterbrand; E W Ely; C J Fisher
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

2.  Human recombinant activated protein C in meningococcal sepsis.

Authors:  Gregory Wcisel; David Joyce; Arna Gudmundsdottir; D Michael Shasby
Journal:  Chest       Date:  2002-01       Impact factor: 9.410

3.  Dysfunction of endothelial protein C activation in severe meningococcal sepsis.

Authors:  S N Faust; M Levin; O B Harrison; R D Goldin; M S Lockhart; S Kondaveeti; Z Laszik; C T Esmon; R S Heyderman
Journal:  N Engl J Med       Date:  2001-08-09       Impact factor: 91.245
  3 in total
  3 in total

1.  Comment on "Early treatment with activated protein C for meningococcal septic shock: case report and literature review" by Hasin et al.

Authors:  Gareth L Thomas; Peter Clark
Journal:  Intensive Care Med       Date:  2005-11-10       Impact factor: 17.440

2.  Early treatment with activated protein C for meningococcal septic shock: case report and literature review.

Authors:  Tal Hasin; David Leibowitz; David Rot; Yoram Weiss; Tova Chajek-Shaul; Ran Nir-Paz
Journal:  Intensive Care Med       Date:  2005-05-20       Impact factor: 17.440

3.  Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies.

Authors:  Jean-Louis Vincent; Simon Nadel; Demetrios J Kutsogiannis; R T Noel Gibney; S Betty Yan; Virginia L Wyss; Joan E Bailey; Carol L Mitchell; Samiha Sarwat; Stephen M Shinall; Jonathan M Janes
Journal:  Crit Care       Date:  2005-05-17       Impact factor: 9.097
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.